Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment [0.03%]
2022年反流性三尖瓣疾病导管介入治疗进展及现状
Jonathan Curio,Ozan M Demir,Matteo Pagnesi et al.
Jonathan Curio et al.
Most patients with severe tricuspid regurgitation lack treatment options because of prohibitive surgical risk. New transcatheter treatments under development and investigation might be able to address this unmet clinical need. This article ...
Simon Kennon
Simon Kennon
Eduardo A Arias,Amit Bhan,Zhan Y Lim et al.
Eduardo A Arias et al.
Treatment of degenerative aortic stenosis has been transformed by transcatheter aortic valve implantation (TAVI) over the past 10-15 years. The success of various technologies has led operators to attempt to broaden the indications, and man...
Johannes Rigger,Colm G Hanratty,Simon J Walsh
Johannes Rigger
[This corrects the article DOI: 10.15420/icr.2018.10.2.].
Published Erratum
Interventional cardiology (London, England). 2019 Feb;14(1):48. DOI:10.15420/icr.2018.35.1 2019
Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip [0.03%]
为什么COAPT成功了而MITRA-FR却失败了？定义MitraClip的合适患者人群
Kimberly Atianzar,Ming Zhang,Zachary Newhart et al.
Kimberly Atianzar et al.
In 2018, the world of functional mitral regurgitation changed with the presentation of two trials - Multicentre Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe Secondary Mitral Regurgitation (MITRA-FR) and...
Philippe Garot,Bertrand Cormier,Jérôme Horvilleur
Philippe Garot
Although left atrial appendage closure (LAAC) has proved non-inferior to oral anticoagulants in patients with AF, there has been recent concern about the occurrence of late complications, especially device-related thrombus (DRT), which was ...
Joel P Giblett,Omar Abdul-Samad,Leonard M Shapiro et al.
Joel P Giblett et al.
Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people it is a benign finding; however, in some the PFO can open widely, enabling a paradoxical embolus to transit from the v...
Didier Tchetche,Chiara de Biase,Bruno Brochado et al.
Didier Tchetche et al.
Transcatheter aortic valve implantation (TAVI) has been in use for 16 years. As there has been a rapid expansion in its use, there is a need to optimise TAVI programmes to ensure efficiency. In this article, the authors discuss the reasons ...
Michael Teitelbaum,Rafail A Kotronias,Luciano A Sposato et al.
Michael Teitelbaum et al.
Cerebrovascular accidents including stroke or transient ischaemic attack are one of the most feared complications after transcatheter aortic valve implantation. Transcatheter aortic valve implantation procedures have been consistently assoc...
Maarten P van Wiechen,Jurgen M Ligthart,Nicolas M Van Mieghem
Maarten P van Wiechen
Endovascular aneurysm repair, transcatheter aortic valve implantation and percutaneous mechanical circulatory support systems have become valuable alternatives to conventional surgery and even preferred strategies for a wide array of clinic...